OTS - Fresenius Kabi starts United for Clinical Nutrition initiative in Europe with first-of-its-kind clinical study assessing critically ill patients in 11 European countries
2019. November 18. 14:00
Bad Homburg, Germany, 18 November, 2019 (APA/OTS) - The first
patients are about to be enrolled in the EuroPN survey, a clinical
study that will assess the nutritional balance and focus on
functional outcomes of critically ill patients in about 100
hospitals across 11 European countries.
The survey is an important scientific project by United for
Clinical Nutrition (UFCN), a global initiative that strives to
fight hospital malnutrition and its detrimental effects on patient
outcomes. Healthcare professionals in about 100 hospitals from
Austria, Belgium, Czech Republic, France, Germany, Hungary, Italy,
Poland, Spain, Sweden and the United Kingdom will collect data on
the nutritional status of their patients as well as caloric and
protein intake during ICU stay. Caloric and protein balance will be
related to clinical outcomes, with a focus on measures of physical
function. The collected data will provide insights into the current
practice of clinical nutrition in critically ill patients and
uncover potential to improve the quality of care.
Disease-related malnutrition can worsen clinical outcomes
In recent times, survival among critically ill patients has
improved significantly. However, disease-related malnutrition is
associated with adverse clinical outcomes, including increased risk
of infections, prolonged ventilation, and increased length of ICU
stay.1 Clinical evidence suggests that adequate nutritional intake
during critical illness improves functional outcomes and patients'
quality of life after ICU discharge.2 Yet, the available evidence -
especially in critically ill patients - is still limited. The
EuroPN survey will provide valuable insights on how clinical
nutrition may improve outcomes in critically ill patients.
UFCN - a global initiative
In 2014, Fresenius Kabi established UFCN to raise awareness for
disease-related malnutrition in countries around the world. After
tailoring dedicated clinical projects and awareness campaigns for
Latin America and Asia, UFCN expands their region of interest to
Europe. The current EuroPN survey marks a cornerstone of the
European initiative. For more information, please visit
www.unitedforclinicalnutrition.com.
References
1. Norman K, Pichard C, Lochs H, et al. Prognostic impact of
disease-related malnutrition Clin Nutr. 2008;27(1):5-15.
2. Wei X, Day AG, Ouellette-Kuntz H, et al. The association
between nutritional adequacy and long-term outcomes in critically
ill patients requiring prolonged mechanical ventilation: a
multicenter cohort study. Crit Care Med. 2015;43(8):1569-7.
# # #
About Fresenius Kabi
Fresenius Kabi is a global healthcare company that specializes
in lifesaving medicines and technologies for infusion, transfusion
and clinical nutrition. The company's products and services are
used to help care for critically and chronically ill patients.
Fresenius Kabi's product portfolio comprises a comprehensive range
of I.V. generic drugs, infusion therapies and clinical nutrition
products as well as the devices for administering these products.
In the field of biosimilars, we focus on autoimmune diseases and
oncology. In 2019, the first biosimilar product by Fresenius Kabi
was launched. Within transfusion medicine and cell technologies,
Fresenius Kabi offers products for collection and processing of
blood and cell components.
With its corporate philosophy of "caring for life", the company
is committed to putting essential medicines and technologies in the
hands of people who help patients and finding the best answers to
the challenges they face.
For more information, please visit www.fresenius-kabi.com.
For press inquiries, please contact:
Nina Espiritu
Edelman GmbH
Barmbeker Str 4, 22303 Hamburg, Germany
T: +49 (0)69 401254-345
nina.espiritu@edelman.com
-------------------------------------------------------------------
Az OTS internetes oldalán található hírek, közlemények, fotók a
forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül
felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett
anyagot tartalmának torzítása nélkül, félreérthetőséget,
rosszindulatú következtetéseket kizáró, az eredeti
szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni.
Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI által
szó szerint továbbított tartalomért minden esetben a beadó a
felelős.
© Copyright MTI nonprofit Zrt.
Az OTS szolgáltatással kapcsolatban további információt a
(06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus
levelező címen kaphat.